Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dalia L Rotstein

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Neurology(R) Neuroimmunology & Neuroinflammation|November 17, 2015
Effect of vitamin D on MS activity by disease-modifying therapy classDalia L Rotstein, Brian C Healy, Muhammad T Malik, et al.
Neurology|March 18, 2018
Temporal trends in multiple sclerosis prevalence and incidence in a large populationDalia L Rotstein, Hong Chen, Andrew S Wilton, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 5, 2024
Investigation of health care use and a possible prodrome before the first attack in NMOSD and MOGADDalia L Rotstein, Mark S Freedman, Andrea Konig, et al.
Multiple Sclerosis and Related Disorders|October 7, 2023
A Canadian case control study investigating demographic and environmental factors associated with MOGADSam Hosseini-Moghaddam, Ruth Ann Marrie, Christina Wolfson, et al.
Expert Review of Neurotherapeutics|April 29, 2016
Anti N-methyl-D-aspartate receptor encephalitis: a game-changer?Corinne E Fischer, Angela C Golas, Tom A Schweizer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 21, 2023
A national case-control study investigating demographic and environmental factors associated with NMOSDDalia L Rotstein, Christina Wolfson, Robert Carruthers, et al.
Multiple Sclerosis and Related Disorders|January 19, 2024
Predicting time to serologic diagnosis of AQP4+ NMOSD based on clinical factors and social determinants of healthDalia L Rotstein, Mark S Freedman, Liesly Lee, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 18, 2025
Risk factors for incident peripartum mental illness in multiple sclerosisRuth Ann Marrie, James M Bolton, Vicki Ling, et al.
Multiple Sclerosis and Related Disorders|March 29, 2025
Comparison of vision-related quality of life in NMOSD and MOGADAdnan A Gassan, Andrea Konig, Rosane Nisenbaum, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|January 30, 2026
Demographic and clinical characteristics of aquaporin-4 antibody positive neuromyelitis optica spectrum disorder in Canadian adultsAmirah I Momen, Mark S Freedman, Giulia Fadda, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Neurology(R) Neuroimmunology & Neuroinflammation|November 17, 2015
Effect of vitamin D on MS activity by disease-modifying therapy classDalia L Rotstein, Brian C Healy, Muhammad T Malik, et al.
Neurology|March 18, 2018
Temporal trends in multiple sclerosis prevalence and incidence in a large populationDalia L Rotstein, Hong Chen, Andrew S Wilton, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 5, 2024
Investigation of health care use and a possible prodrome before the first attack in NMOSD and MOGADDalia L Rotstein, Mark S Freedman, Andrea Konig, et al.
Multiple Sclerosis and Related Disorders|October 7, 2023
A Canadian case control study investigating demographic and environmental factors associated with MOGADSam Hosseini-Moghaddam, Ruth Ann Marrie, Christina Wolfson, et al.
Expert Review of Neurotherapeutics|April 29, 2016
Anti N-methyl-D-aspartate receptor encephalitis: a game-changer?Corinne E Fischer, Angela C Golas, Tom A Schweizer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 21, 2023
A national case-control study investigating demographic and environmental factors associated with NMOSDDalia L Rotstein, Christina Wolfson, Robert Carruthers, et al.
Multiple Sclerosis and Related Disorders|January 19, 2024
Predicting time to serologic diagnosis of AQP4+ NMOSD based on clinical factors and social determinants of healthDalia L Rotstein, Mark S Freedman, Liesly Lee, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 18, 2025
Risk factors for incident peripartum mental illness in multiple sclerosisRuth Ann Marrie, James M Bolton, Vicki Ling, et al.
Multiple Sclerosis and Related Disorders|March 29, 2025
Comparison of vision-related quality of life in NMOSD and MOGADAdnan A Gassan, Andrea Konig, Rosane Nisenbaum, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|January 30, 2026
Demographic and clinical characteristics of aquaporin-4 antibody positive neuromyelitis optica spectrum disorder in Canadian adultsAmirah I Momen, Mark S Freedman, Giulia Fadda, et al.
Pageof 5